Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

3 Must-Have Healthcare Mutual Funds for Steady Returns

Published 11/18/2021, 04:41 AM
Updated 07/09/2023, 06:31 AM

Investors often rely on the healthcare sector to safeguard their investments. This is because healthcare services do not see their demand varying much with market conditions and thus offer sufficient protection to the capital invested.

Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate stable cash flows, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.

Below we share with you three top-ranked healthcare mutual funds — Fidelity Advisor Health Care Fund Class M FACTX, T. Rowe Price Health Sciences Fund PRHSX and Fidelity Select Health Care Portfolio FSPHX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.

Fidelity Advisor Health Care Fund Class M aims for capital growth. FACTX invests the majority of its assets in common stocks of companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. Fidelity Advisor Health Care Fund Class M invests in both U.S. as well as non-U.S. issuers.

Fidelity Advisor Health Care Fund Class M has three-year annualized returns of 17.7%. Edward Yoon is the fund manager of FACTX since 2008.

T. Rowe Price Health Sciences Fund is non-diversified and invests more than 80% of its assets in common stocks of companies engaged in various activities in healthcare, medicine or life sciences. PRHSX mostly invests in mid- and large-capitalization companies.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

T. Rowe Price Health Sciences Fund has three-year annualized returns of 21.8%. PRHSX has an expense ratio of 0.76% compared with the category average of 1.03%.

Fidelity Select Health Care Portfolio is a non-diversified fund that aims for capital appreciation. FSPHX invests the majority of its assets in common stocks of companies engaged in designing, manufacturing, or sale of products or services related to healthcare or medicine.

Fidelity Select Health Care Portfolio has three-year annualized returns of 20.2%. As of the end of September 2021, FSPHX held 131 issues with 8.9% of its assets invested in UnitedHealth Group Inc (NYSE:UNH).

To view the Zacks Rank and past performance of all healthcare mutual funds, investors can click here to see the complete list of funds.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>


Infrastructure Stock Boom to Sweep America

A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.

The only question is “Will you get into the right stocks early when their growth potential is greatest?”

Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Get Your Free (FSPHX): Fund Analysis Report

Get Your Free (PRHSX): Fund Analysis Report

Get Your Free (FACTX): Fund Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.